Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
William Fraser Symmans
Based on 52 articles published since 2009
(Why 52 articles?)
||||
Expertise Level
The expertise of William Fraser Symmans ranks in the
  • Top 0.14%
  • ... of 287,191 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 52 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Symmans, William Fraser   ·   Symmans, William F   ·   Symmans, W Fraser   ·   Symmans, W F   ·   Symmans, W
Work Locations
Details
Most likely:    University of Texas Houston   Contact    
2019
  • Department of Diagnostic Radiology, Unit 1350, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Department of Diagnostic Radiology, Unit 1350, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Department of Biostatistics, Unit 1411, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Department of Breast Surgical Oncology, Unit 1434, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Department of Diagnostic Radiology, Unit 1350, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Department of Diagnostic Radiology, Unit 1350, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Department of Diagnostic Radiology, Unit 1350, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Department of Diagnostic Radiology, Unit 1350, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Department of Diagnostic Radiology, Unit 1350, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Department of Pathology, Unit 085, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Department of Pathology, Unit 085, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Department of Pathology, Unit 085, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Department of Breast Medical Oncology, Unit 1354, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Department of Breast Medical Oncology, Unit 1354, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Department of Breast Medical Oncology, Unit 1354, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Department of Diagnostic Radiology, Unit 1350, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Pubmed 31005169
2018
  • German Breast Group, Neu-Isenburg, Germany; Centre for Haematology and Oncology Bethanien, Frankfurt, Germany. Electronic address: · Baylor University Medical Center, Dallas, TX, USA. · HELIOS Klinikum Berlin-Buch, Berlin, Germany. · Women & Infants Hospital of Rhode Island, Providence, RI, USA. · University of California San Francisco Hellen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · AbbVie Inc, North Chicago, IL, USA. · Ulm University, Ulm, Germany. · Brigham and Women's Hospital, Boston, MA, USA. · German Breast Group, Neu-Isenburg, Germany. · National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA, USA. · Texas Oncology, US Oncology, Dallas, TX, USA. · Alicante University General Hospital, ISABIAL, GEICAM (Spanish Breast Cancer Research Group), Alicante, Spain. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA, USA; Magee-Womens Hospital, Pittsburgh, PA, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA, USA; Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · Pubmed 29501363
  • David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA. Electronic address: · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CiberOnc, GEICAM, Madrid, Spain. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Asan Medical Center, University of Ulsan College of Medicine, Songpa-gu, Seoul, Korea. · National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. · Breast Center, University of Munich (LMU), Munich, Germany. · Moscow City Oncology Hospital 62, Moscow, Russia. · Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. · Centre René Gauducheau, St Herblain cedex, France. · McGill University, Sir Mortimer B Davis Jewish General Hospital, Montreal, QC, Canada. · University Hospital Erlangen, Department of Obstetrics and Gynecology, Friedrich-Alexander-Universität Erlangen, Comprehensive Cancer Center Erlangen-Europäische Metropolregion Nuremberg, Erlangen, Germany. · Translational Research in Oncology, Biopark, Paris, France. · Translational Research in Oncology, Luis Alberto de Herrera, Montevideo, Uruguay. · F Hoffmann-La Roche, Basel, Switzerland. · Genentech, San Francisco, CA, USA. · Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. · David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA. · Pubmed 29175149
  • Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, 77054, TX, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, 77054, TX, USA. · Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, 77054, TX, USA. · Center for Co-Clinical Trials Research, The University of Texas MD Anderson Cancer Center, Houston, 77054, TX, USA. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, 77030, TX, USA. · Department of Integrative Biology and Pharmacology, The University of Texas Health Science Center, Houston, 77030, TX, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, 77030, TX, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, 77030, TX, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, 77030, TX, USA. · Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, 77054, TX, USA. · Pubmed 30498242
  • Departments of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Flow Cytometry and Cell Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. · Department of Medicine and Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Faculty of Medicine and Health Sciences, Center for Oncological Research, University of Antwerp, Antwerp, Belgium. · Department of Breast Surgical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, Unit 1202, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA. · Pubmed 29858753
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Hematology & Oncology, Northwestern University, Chicago, IL. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: · Pubmed 29689244
  • Department of Oncology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA. · Department of Biomedical Data Science, Stanford University, Stanford, California, USA. · Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands. · Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany. · Department of Clinical Pharmacology, University Hospital, Tuebingen, Germany. · Department of Pharmacy and Biochemistry, University of Tuebingen, Tuebingen, Germany. · Division of Statistical Genomics, Washington University School of Medicine, St. Louis, Missouri, USA. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Moffitt Cancer Center, Tampa, Florida, USA. · Center for Personalized Therapeutics, University of Chicago, Chicago, Illinois, USA. · Division of Human Genetics, National Cancer Center, Research Institute, Tokyo, Japan. · Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Kansas City and Department of Pediatrics, University of Missouri-Kansas City, Kansas City, Missouri, USA. · International Expertcenter Pharmacogenetics, Dept Clinical Chemistry, Erasmus MC, Rotterdam, The Netherlands. · LKCH UMC Utrecht, The Netherlands. · Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. · Pubmed 29385237
2017
  • W. Fraser Symmans, Caimiao Wei, Rebekah Gould, Xian Yu, Ya Zhang, Maheshwari Ramineni, Kelly Hunt, Thomas A. Buchholz, Vicente Valero, Aman U. Buzdar, Wei Yang, Abenaa M. Brewster, Stacy Moulder, and Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston · Andrew Walls, Uniformed Services University of the Health Sciences, San Antonio, TX · Mei Liu, The General Hospital of People's Liberation Army, Beijing, China · Alex Bousamra, Allegheny General Hospital, Pittsburgh, PA · Bruno Sinn, Charite-Universitatsmedizin, Berlin, Germany · and Lajos Pusztai and Christos Hatzis, Yale University School of Medicine, New Haven, CT. · Pubmed 28135148
  • Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Pathology Administration, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA. · Department of Cellular and Molecular Medicine, University of Arizona Cancer Center, Tucson, Arizona, USA. · School of Medicine, University of Nottingham, Nottingham, UK. · Quintiles Transnational Corp, Denver, Colorado, USA. · Pubmed 27881578
2016
  • Department of Pathology, Yale University, New Haven, CT, USA. · The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 27380637
  • From University of California, San Francisco (UCSF) (H.S.R., C.Y., L.J.V., M.B.B., N.M.H., A.J.C., C.E., J.L., S.E.D., G.L.H., L.J.E.), and QuantumLeap Healthcare Collaborative (M.P.), San Francisco, Buck Institute for Research and Aging, Novato (C.Y.), University of California, Davis, Davis (M.H.), University of California San Diego, San Diego (A.M.W., R.S.), and University of Southern California, Los Angeles (D.T.) - all in California · University of Chicago (O.I.O., R.N.), and Loyola University (K.S.A.), Chicago · University of Pennsylvania, Philadelphia (A.D.) · Gemini Group, Ann Arbor, MI (J.P.) · University of Texas M.D. Anderson Cancer Center, Houston (W.F.S., L.P., S.L.M., D.A.B.), UT Southwestern Medical Center, Dallas (D.M.E., B.B.H.), and Berry Consultants, Austin (A.S., D.A.B.) - all in Texas · University of Minnesota, Minneapolis (D.Y.), and Mayo Clinic, Rochester (J.C.B., T.C.H.) - both in Minnesota · Swedish Medical Center, Seattle (H.G.K.) · Georgetown Lombardi Comprehensive Cancer Center, Washington, DC (M.C.L., C.I.) · University of Kansas, Lawrence (Q.J.K.) · University of Arizona, Tucson (J.E.L., R.K.V.), and Mayo Clinic, Scottsdale (D.W.N.) - both in Arizona · Oregon Health and Sciences University, Portland (S.Y.C., K.A.K.) · University of Denver, Denver (A.D.E.) · Inova Fairfax Hospital, Falls Church, VA (K.K.E.) · and Emory University, Atlanta (W.C.W.). · Pubmed 27406347
  • From University of California, San Francisco (J.W.P., C.Y., L.J.V., N.M.H., M.B.B., A.J.C., M.M., J.L., S.E.D., G.L.H., L.J.E.), and QuantumLeap Healthcare Collaborative (M.P.), San Francisco, Buck Institute for Research and Aging, Novato (C.Y.), University of California, Davis, Davis (M.H.), University of California, San Diego, San Diego (A.M.W., R.S., T.H.), and University of Southern California, Los Angeles (D.T.) - all in California · Georgetown Lombardi Comprehensive Cancer Center, Washington, DC (M.C.L., C.I.) · University of Minnesota, Minneapolis (D.Y., T.C.H.), and Mayo Clinic, Rochester (J.C.B.) - both in Minnesota · M.D. Anderson Cancer Center, Houston (W.F.S., L.P., S.L.M., D.A.B.), University of Texas Southwestern Medical Center, Dallas (D.M.E., B.B.H.), and Berry Consultants, Austin (A.S., D.A.B.) - all in Texas · Gemini Group, Ann Arbor, MI (J.P.) · University of Pennsylvania, Philadelphia (A.D.) · Oregon Health and Sciences University, Portland (S.Y.C., K.A.K.) · Swedish Medical Center, Seattle (H.G.K.) · University of Chicago (R.N.) and Loyola University (K.S.A.) - both in Chicago · Inova Fairfax Hospital, Falls Church, VA (K.K.E.) · University of Denver, Denver (A.D.E.) · Mayo Clinic, Scottsdale (D.W.N.), and University of Arizona, Tucson (J.E.L., R.K.V.) - both in Arizona · University of Kansas, Lawrence (Q.J.K.) · and Emory University, Atlanta (W.C.W.). · Pubmed 27406346
  • Department of Medicine, Yale School of Medicine, Yale University, New Haven, Connecticut, United States of America. · MTA TTK Lendulet Cancer Biomarker Research Group, Research Center for Natural Sciences, Budapest, Hungary. · 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary. · Department of Genetics, Yale School of Medicine, Yale University, New Haven, Connecticut, United States of America. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Yale Cancer Center, New Haven, Connecticut, United States of America. · Pubmed 27959926
  • Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Centre, Houston, TX, USA. · Metastasis Research Centre, The University of Texas MD Anderson Cancer Centre, Houston, TX, USA. · Center for Stem Cells and Developmental Biology, The University of Texas MD Anderson Cancer Centre, Houston, TX, USA. · Pubmed 27064522
  • Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston4Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston. · Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston. · Pubmed 26986538
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Hematology and Oncology, Northwestern University, Chicago, IL, USA. · Pubmed 26916073
  • Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston. · Center for Cancer and Blood Disorders, Arlington, Texas. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston. · Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston. · Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Houston. · Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston. · Pubmed 26720612
  • Department of Internal Medicine, Yale School of Medicine, Yale Cancer Center, New Haven, Connecticut. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Internal Medicine, Yale School of Medicine, Yale Cancer Center, New Haven, Connecticut. · Department of Surgery, Yale School of Medicine, Yale Cancer Center, New Haven, Connecticut. · Pubmed 26286912
2015
  • Department of Histopathology and NIH Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, UK. · Department of Pathology, Yale University, New Haven, CT, USA. · Department of Pathology, European Institute of Oncology and University of Milan, Milan, Italy. · Edinburgh Cancer Research UK Centre,University of Edinburgh, Edinburgh, UK. · Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. · Institute of Pathology, Charité Hospital, Berlin, Germany. · Department of Biopathology, Institut Bergonié, Bordeaux, France. · Department of Pathology, Centre Jean Perrin and Université d'Auvergne, Clermont-Ferrand, France. · Division of Subspecialty General Surgery, Mayo Clinic, Rochester, MN, USA. · Early Drug Development for Innovative Therapies Division, European Institute of Oncology, Milan, Italy. · Edinburgh Breast Unit, Western General Hospital, Edinburgh, UK. · Carol Franc Buck Breast Care Center, University of California, San Francisco, CA, USA. · Department of Radiotherapy and Radiation Oncology, Landeskrankenhaus, Paracelsus Medical University, Salzburg, Austria. · Department of Gynecology and Obstetrics, Interdisciplinary Breast Center, Klinikum Esslingen, Esslingen, Germany. · Institute of Pathology, Medical University of Graz, Graz, Austria. · Department of Gynecology, General Hospital Leoben, Leoben, Austria. · German Breast Group, Neu-Isenburg, and Department of Gynecology and Obstetrics, University Women's Hospital, Frankfurt, Germany. · Department of Radiation Oncology, Ohio State University, Columbus, OH, USA. · Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26205180
  • Catherine Van Poznak and Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI · Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA · Robert C. Bast, Ana M. Gonzalez-Angulo, and William F. Symmans, University of Texas MD Anderson Cancer Center, Houston · Robert G. Mennel, Texas Oncology, Dallas, TX · Massimo Cristofanilli, Thomas Jefferson University-Kimmel Cancer Center, Philadelphia, PA · Matthew P. Goetz and Minetta C. Liu, Mayo Clinic, Rochester, MN · David G. Hicks, University of Rochester Medical Center, Rochester, NY · Elizabeth G. Hill, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC · Wanda Lucas, Georgetown University, Washington, DC · Ingrid A. Mayer, Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TN · and Lyndsay N. Harris, Seidman Cancer Center, Case Western Reserve University, Cleveland, OH. · Pubmed 26195705
  • Department of Pathology, Yale University, New Haven, USA · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston. · Division of Subspecialty General Surgery, Mayo Clinic, Rochester, USA. · Oncology Centre, Cambridge University Hospitals National Health Services Foundation Trust, Cambridge, UK. · Division of Early Drug Development for Innovative Therapies, European Institute of Oncology, Milan, Italy. · Edinburgh Breast Unit, Western General Hospital, Edinburgh, UK. · Carol Franc Buck Breast Care Center, University of California, San Francisco, USA. · Department of Radiotherapy and Radiation Oncology, Landeskrankenhaus, Paracelsus Medical University, Salzburg, Austria. · Department of Gynecology and Obstetrics, Interdisciplinary Breast Center, Klinikum Esslingen, Essligen, Germany. · Institute of Pathology, Medical University of Graz, Graz Breast Center Salzburg, Paracelsus Medical University, University Hospital Salzburg, Salzburg, Austria. · German Breast Group, Neu-Isenburg, and University Women's Hospital, Frankfurt, Germany. · Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center, Columbus. · Department of Diagnostic Radiology, The University of Texas M.D. Anderson Cancer Center, Houston. · Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, USA. · Institute of Pathology, Charité Hospital, Campus Mitte, Berlin, Germany. · Department of Biopathology, Institut Bergonié, Bordeaux. · Centre Jean Perrin, Clermont-Ferrand, and Université d'Auvergne, France. · Department of Pathology, European Institute of Oncology and University of Milan, Milan, Italy. · Edinburgh Cancer Research UK Centre, The University of Edinburgh, Edinburgh, UK. · Pubmed 26019189
  • Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut. · Department of Surgery, Curie Institute, Paris, France. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26275950
  • Departments of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut, United States of America. · Pubmed 26136146
  • 1] Institute of Pathology, Medical University of Graz, Graz, Austria [2] Department of Gynecology, General Hospital Leoben, Leoben, Austria. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA. · Department of Pathology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, UT, USA. · MLD Pathology, Houston, TX, USA. · Pubmed 25932963
2014
  • Department of Breast Medical Oncology Department of Systems Biology · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston. · Department of Breast Medical Oncology. · Genenetech, San Francisco. · Departments of Biostatistics. · Clinical Cancer Prevention. · Radiology. · Pathology, The University of Texas MD Anderson Cancer Center, Houston. · Division of Hematology-Oncology, Yale University, New Haven. · Department of Systems Biology. · Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, USA. · Pubmed 24669015
  • Section of Medical Oncology, Yale Cancer Center, Yale School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA. · Department of Pathology, UT M.D. Anderson Cancer Center, P.O. Box 85, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Department of Bioinformatics and Computational Biology, UT M.D. Anderson Cancer Center, P.O. Box 301402, Houston, TX 77230, USA. · Section of Medical Oncology, Yale Cancer Center, Yale School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA. Electronic address: · Pubmed 24602449
2013
  • Affiliations of authors: Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD (MCP, LMM) · Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada (SCYL, DG, EM, TON) · Department of Laboratory Medicine and Pathology, University of Alberta, Alberta, Canada (JCH) · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy (MGM) · Division of Pathology and Laboratory Medicine, European Institute of Oncology, and University of Milan, Milan, Italy (GV) · Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom (LAZ) · Department of Pathology, Centre Jean Perrin, Clermont-Ferrand, and Université d'Auvergne, France (FP-L) · Transformative Pathology, Ontario Institute for Cancer Research, Toronto, Ontario, Canada (JMSB) · PhenoPath Laboratories, Seattle, WA (AMG) · Department of Pathology, MD Anderson Cancer Center, Houston, TX (WFS) · Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, United Kingdom (TP) · The EMMES Corporation, Rockville, MD (RAE) · Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI (DFH) · Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom (MD) · on behalf of the International Ki67 in Breast Cancer Working Group of the Breast International Group and North American Breast Cancer Group. · Pubmed 24203987
2017
  • *Mayo Clinic, Rochester, MN †Alliance Statistics and Data Center, Weill Medical College of Cornell University, New York, NY ‡Alliance Statistics and Data Center, Duke University, Durham, NC §The University of Texas MD Anderson Cancer Center, Houston, TX ¶NRG Oncology and The Allegheny Health Network, Pittsburgh, PA ||SWOG and University of Washington Medical Center, Seattle, WA. · Pubmed 28657941
  • Houston, Texas From the Departments of Plastic and Reconstructive Surgery, Biostatistics, Pathology, Breast Medical Oncology, Surgical Oncology, and Radiation Oncology, The University of Texas M. D. Anderson Cancer Center. · Pubmed 28234813
2014
  • Yale University School of Medicine, New Haven, Connecticut, USA; Foundation Medicine, Cambridge, Massachusetts, USA; MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 24710307
2013
  • Authors' Affiliations: Morgan Welch Inflammatory Breast Cancer Research Program and Clinic; Departments of Breast Medical Oncology, Bioinformatics and Computational Biology, Pathology, and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; and Department of Biochemistry, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee. · Pubmed 23948975
Probable:    Baylor College of Medicine   Contact    
2017
  • Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Pathology Administration, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA. · Department of Cellular and Molecular Medicine, University of Arizona Cancer Center, Tucson, Arizona, USA. · School of Medicine, University of Nottingham, Nottingham, UK. · Quintiles Transnational Corp, Denver, Colorado, USA. · Pubmed 27881578
Probable:    University of Texas Austin      
2016
  • From University of California, San Francisco (UCSF) (H.S.R., C.Y., L.J.V., M.B.B., N.M.H., A.J.C., C.E., J.L., S.E.D., G.L.H., L.J.E.), and QuantumLeap Healthcare Collaborative (M.P.), San Francisco, Buck Institute for Research and Aging, Novato (C.Y.), University of California, Davis, Davis (M.H.), University of California San Diego, San Diego (A.M.W., R.S.), and University of Southern California, Los Angeles (D.T.) - all in California · University of Chicago (O.I.O., R.N.), and Loyola University (K.S.A.), Chicago · University of Pennsylvania, Philadelphia (A.D.) · Gemini Group, Ann Arbor, MI (J.P.) · University of Texas M.D. Anderson Cancer Center, Houston (W.F.S., L.P., S.L.M., D.A.B.), UT Southwestern Medical Center, Dallas (D.M.E., B.B.H.), and Berry Consultants, Austin (A.S., D.A.B.) - all in Texas · University of Minnesota, Minneapolis (D.Y.), and Mayo Clinic, Rochester (J.C.B., T.C.H.) - both in Minnesota · Swedish Medical Center, Seattle (H.G.K.) · Georgetown Lombardi Comprehensive Cancer Center, Washington, DC (M.C.L., C.I.) · University of Kansas, Lawrence (Q.J.K.) · University of Arizona, Tucson (J.E.L., R.K.V.), and Mayo Clinic, Scottsdale (D.W.N.) - both in Arizona · Oregon Health and Sciences University, Portland (S.Y.C., K.A.K.) · University of Denver, Denver (A.D.E.) · Inova Fairfax Hospital, Falls Church, VA (K.K.E.) · and Emory University, Atlanta (W.C.W.). · Pubmed 27406347
  • From University of California, San Francisco (J.W.P., C.Y., L.J.V., N.M.H., M.B.B., A.J.C., M.M., J.L., S.E.D., G.L.H., L.J.E.), and QuantumLeap Healthcare Collaborative (M.P.), San Francisco, Buck Institute for Research and Aging, Novato (C.Y.), University of California, Davis, Davis (M.H.), University of California, San Diego, San Diego (A.M.W., R.S., T.H.), and University of Southern California, Los Angeles (D.T.) - all in California · Georgetown Lombardi Comprehensive Cancer Center, Washington, DC (M.C.L., C.I.) · University of Minnesota, Minneapolis (D.Y., T.C.H.), and Mayo Clinic, Rochester (J.C.B.) - both in Minnesota · M.D. Anderson Cancer Center, Houston (W.F.S., L.P., S.L.M., D.A.B.), University of Texas Southwestern Medical Center, Dallas (D.M.E., B.B.H.), and Berry Consultants, Austin (A.S., D.A.B.) - all in Texas · Gemini Group, Ann Arbor, MI (J.P.) · University of Pennsylvania, Philadelphia (A.D.) · Oregon Health and Sciences University, Portland (S.Y.C., K.A.K.) · Swedish Medical Center, Seattle (H.G.K.) · University of Chicago (R.N.) and Loyola University (K.S.A.) - both in Chicago · Inova Fairfax Hospital, Falls Church, VA (K.K.E.) · University of Denver, Denver (A.D.E.) · Mayo Clinic, Scottsdale (D.W.N.), and University of Arizona, Tucson (J.E.L., R.K.V.) - both in Arizona · University of Kansas, Lawrence (Q.J.K.) · and Emory University, Atlanta (W.C.W.). · Pubmed 27406346
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 52 total) written by William Fraser Symmans about Breast Neoplasms:

  • Imaging features of triple-negative breast cancers according to androgen receptor status. 2019
  • Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial. 2018
  • Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial. 2018
  • High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer. 2018
  • Mammary stem cell and macrophage markers are enriched in normal tissue adjacent to inflammatory breast cancer. 2018
  • Decreased expression of microRNA-26b in locally advanced and inflammatory breast cancer. 2018
  • Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy. 2018
  • Tumor Biology and Response to Chemotherapy Impact Breast Cancer-specific Survival in Node-positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: Long-term Follow-up From ACOSOG Z1071 (Alliance). 2017
  • Performance of Mid-Treatment Breast Ultrasound and Axillary Ultrasound in Predicting Response to Neoadjuvant Chemotherapy by Breast Cancer Subtype. 2017
  • Molecular Profiling Using Breast Cancer Subtype to Plan for Breast Reconstruction. 2017
Show List of Full Article Records
Google Searches

Learn more about William Fraser Symmans using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Texas Houston
Baylor College of Medicine
University of Texas Austin
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Texas Houston
2019
  • Department of Diagnostic Radiology, Unit 1350, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Department of Diagnostic Radiology, Unit 1350, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Department of Biostatistics, Unit 1411, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Department of Breast Surgical Oncology, Unit 1434, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Department of Diagnostic Radiology, Unit 1350, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Department of Diagnostic Radiology, Unit 1350, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Department of Diagnostic Radiology, Unit 1350, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Department of Diagnostic Radiology, Unit 1350, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Department of Diagnostic Radiology, Unit 1350, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Department of Pathology, Unit 085, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Department of Pathology, Unit 085, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Department of Pathology, Unit 085, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Department of Breast Medical Oncology, Unit 1354, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Department of Breast Medical Oncology, Unit 1354, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Department of Breast Medical Oncology, Unit 1354, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Department of Diagnostic Radiology, Unit 1350, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address: · Pubmed 31005169
2018
  • German Breast Group, Neu-Isenburg, Germany; Centre for Haematology and Oncology Bethanien, Frankfurt, Germany. Electronic address: · Baylor University Medical Center, Dallas, TX, USA. · HELIOS Klinikum Berlin-Buch, Berlin, Germany. · Women & Infants Hospital of Rhode Island, Providence, RI, USA. · University of California San Francisco Hellen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · AbbVie Inc, North Chicago, IL, USA. · Ulm University, Ulm, Germany. · Brigham and Women's Hospital, Boston, MA, USA. · German Breast Group, Neu-Isenburg, Germany. · National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA, USA. · Texas Oncology, US Oncology, Dallas, TX, USA. · Alicante University General Hospital, ISABIAL, GEICAM (Spanish Breast Cancer Research Group), Alicante, Spain. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA, USA; Magee-Womens Hospital, Pittsburgh, PA, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · National Surgical Adjuvant Breast and Bowel Project Foundation, Pittsburgh, PA, USA; Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA. · Pubmed 29501363
  • David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA. Electronic address: · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, CiberOnc, GEICAM, Madrid, Spain. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Asan Medical Center, University of Ulsan College of Medicine, Songpa-gu, Seoul, Korea. · National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. · Breast Center, University of Munich (LMU), Munich, Germany. · Moscow City Oncology Hospital 62, Moscow, Russia. · Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. · Centre René Gauducheau, St Herblain cedex, France. · McGill University, Sir Mortimer B Davis Jewish General Hospital, Montreal, QC, Canada. · University Hospital Erlangen, Department of Obstetrics and Gynecology, Friedrich-Alexander-Universität Erlangen, Comprehensive Cancer Center Erlangen-Europäische Metropolregion Nuremberg, Erlangen, Germany. · Translational Research in Oncology, Biopark, Paris, France. · Translational Research in Oncology, Luis Alberto de Herrera, Montevideo, Uruguay. · F Hoffmann-La Roche, Basel, Switzerland. · Genentech, San Francisco, CA, USA. · Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. · David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA. · Pubmed 29175149
  • Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, 77054, TX, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, 77054, TX, USA. · Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, 77054, TX, USA. · Center for Co-Clinical Trials Research, The University of Texas MD Anderson Cancer Center, Houston, 77054, TX, USA. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, 77030, TX, USA. · Department of Integrative Biology and Pharmacology, The University of Texas Health Science Center, Houston, 77030, TX, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, 77030, TX, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, 77030, TX, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, 77030, TX, USA. · Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, 77054, TX, USA. · Pubmed 30498242
  • Departments of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Flow Cytometry and Cell Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. · Department of Medicine and Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Faculty of Medicine and Health Sciences, Center for Oncological Research, University of Antwerp, Antwerp, Belgium. · Department of Breast Surgical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · MD Anderson Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Morgan Welch Inflammatory Breast Cancer Clinic and Research Program, Unit 1202, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA. · Pubmed 29858753
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Hematology & Oncology, Northwestern University, Chicago, IL. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: · Pubmed 29689244
  • Department of Oncology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA. · Department of Biomedical Data Science, Stanford University, Stanford, California, USA. · Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands. · Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany. · Department of Clinical Pharmacology, University Hospital, Tuebingen, Germany. · Department of Pharmacy and Biochemistry, University of Tuebingen, Tuebingen, Germany. · Division of Statistical Genomics, Washington University School of Medicine, St. Louis, Missouri, USA. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Moffitt Cancer Center, Tampa, Florida, USA. · Center for Personalized Therapeutics, University of Chicago, Chicago, Illinois, USA. · Division of Human Genetics, National Cancer Center, Research Institute, Tokyo, Japan. · Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Kansas City and Department of Pediatrics, University of Missouri-Kansas City, Kansas City, Missouri, USA. · International Expertcenter Pharmacogenetics, Dept Clinical Chemistry, Erasmus MC, Rotterdam, The Netherlands. · LKCH UMC Utrecht, The Netherlands. · Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. · Pubmed 29385237
2017
  • W. Fraser Symmans, Caimiao Wei, Rebekah Gould, Xian Yu, Ya Zhang, Maheshwari Ramineni, Kelly Hunt, Thomas A. Buchholz, Vicente Valero, Aman U. Buzdar, Wei Yang, Abenaa M. Brewster, Stacy Moulder, and Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston · Andrew Walls, Uniformed Services University of the Health Sciences, San Antonio, TX · Mei Liu, The General Hospital of People's Liberation Army, Beijing, China · Alex Bousamra, Allegheny General Hospital, Pittsburgh, PA · Bruno Sinn, Charite-Universitatsmedizin, Berlin, Germany · and Lajos Pusztai and Christos Hatzis, Yale University School of Medicine, New Haven, CT. · Pubmed 28135148
  • Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Pathology Administration, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA. · Department of Cellular and Molecular Medicine, University of Arizona Cancer Center, Tucson, Arizona, USA. · School of Medicine, University of Nottingham, Nottingham, UK. · Quintiles Transnational Corp, Denver, Colorado, USA. · Pubmed 27881578
2016
  • Department of Pathology, Yale University, New Haven, CT, USA. · The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 27380637
  • From University of California, San Francisco (UCSF) (H.S.R., C.Y., L.J.V., M.B.B., N.M.H., A.J.C., C.E., J.L., S.E.D., G.L.H., L.J.E.), and QuantumLeap Healthcare Collaborative (M.P.), San Francisco, Buck Institute for Research and Aging, Novato (C.Y.), University of California, Davis, Davis (M.H.), University of California San Diego, San Diego (A.M.W., R.S.), and University of Southern California, Los Angeles (D.T.) - all in California · University of Chicago (O.I.O., R.N.), and Loyola University (K.S.A.), Chicago · University of Pennsylvania, Philadelphia (A.D.) · Gemini Group, Ann Arbor, MI (J.P.) · University of Texas M.D. Anderson Cancer Center, Houston (W.F.S., L.P., S.L.M., D.A.B.), UT Southwestern Medical Center, Dallas (D.M.E., B.B.H.), and Berry Consultants, Austin (A.S., D.A.B.) - all in Texas · University of Minnesota, Minneapolis (D.Y.), and Mayo Clinic, Rochester (J.C.B., T.C.H.) - both in Minnesota · Swedish Medical Center, Seattle (H.G.K.) · Georgetown Lombardi Comprehensive Cancer Center, Washington, DC (M.C.L., C.I.) · University of Kansas, Lawrence (Q.J.K.) · University of Arizona, Tucson (J.E.L., R.K.V.), and Mayo Clinic, Scottsdale (D.W.N.) - both in Arizona · Oregon Health and Sciences University, Portland (S.Y.C., K.A.K.) · University of Denver, Denver (A.D.E.) · Inova Fairfax Hospital, Falls Church, VA (K.K.E.) · and Emory University, Atlanta (W.C.W.). · Pubmed 27406347
  • From University of California, San Francisco (J.W.P., C.Y., L.J.V., N.M.H., M.B.B., A.J.C., M.M., J.L., S.E.D., G.L.H., L.J.E.), and QuantumLeap Healthcare Collaborative (M.P.), San Francisco, Buck Institute for Research and Aging, Novato (C.Y.), University of California, Davis, Davis (M.H.), University of California, San Diego, San Diego (A.M.W., R.S., T.H.), and University of Southern California, Los Angeles (D.T.) - all in California · Georgetown Lombardi Comprehensive Cancer Center, Washington, DC (M.C.L., C.I.) · University of Minnesota, Minneapolis (D.Y., T.C.H.), and Mayo Clinic, Rochester (J.C.B.) - both in Minnesota · M.D. Anderson Cancer Center, Houston (W.F.S., L.P., S.L.M., D.A.B.), University of Texas Southwestern Medical Center, Dallas (D.M.E., B.B.H.), and Berry Consultants, Austin (A.S., D.A.B.) - all in Texas · Gemini Group, Ann Arbor, MI (J.P.) · University of Pennsylvania, Philadelphia (A.D.) · Oregon Health and Sciences University, Portland (S.Y.C., K.A.K.) · Swedish Medical Center, Seattle (H.G.K.) · University of Chicago (R.N.) and Loyola University (K.S.A.) - both in Chicago · Inova Fairfax Hospital, Falls Church, VA (K.K.E.) · University of Denver, Denver (A.D.E.) · Mayo Clinic, Scottsdale (D.W.N.), and University of Arizona, Tucson (J.E.L., R.K.V.) - both in Arizona · University of Kansas, Lawrence (Q.J.K.) · and Emory University, Atlanta (W.C.W.). · Pubmed 27406346
  • Department of Medicine, Yale School of Medicine, Yale University, New Haven, Connecticut, United States of America. · MTA TTK Lendulet Cancer Biomarker Research Group, Research Center for Natural Sciences, Budapest, Hungary. · 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary. · Department of Genetics, Yale School of Medicine, Yale University, New Haven, Connecticut, United States of America. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Yale Cancer Center, New Haven, Connecticut, United States of America. · Pubmed 27959926
  • Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Centre, Houston, TX, USA. · Metastasis Research Centre, The University of Texas MD Anderson Cancer Centre, Houston, TX, USA. · Center for Stem Cells and Developmental Biology, The University of Texas MD Anderson Cancer Centre, Houston, TX, USA. · Pubmed 27064522
  • Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston4Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston. · Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston. · Pubmed 26986538
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Hematology and Oncology, Northwestern University, Chicago, IL, USA. · Pubmed 26916073
  • Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston. · Center for Cancer and Blood Disorders, Arlington, Texas. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston. · Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston. · Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Houston. · Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston. · Pubmed 26720612
  • Department of Internal Medicine, Yale School of Medicine, Yale Cancer Center, New Haven, Connecticut. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Internal Medicine, Yale School of Medicine, Yale Cancer Center, New Haven, Connecticut. · Department of Surgery, Yale School of Medicine, Yale Cancer Center, New Haven, Connecticut. · Pubmed 26286912
2015
  • Department of Histopathology and NIH Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, UK. · Department of Pathology, Yale University, New Haven, CT, USA. · Department of Pathology, European Institute of Oncology and University of Milan, Milan, Italy. · Edinburgh Cancer Research UK Centre,University of Edinburgh, Edinburgh, UK. · Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. · Institute of Pathology, Charité Hospital, Berlin, Germany. · Department of Biopathology, Institut Bergonié, Bordeaux, France. · Department of Pathology, Centre Jean Perrin and Université d'Auvergne, Clermont-Ferrand, France. · Division of Subspecialty General Surgery, Mayo Clinic, Rochester, MN, USA. · Early Drug Development for Innovative Therapies Division, European Institute of Oncology, Milan, Italy. · Edinburgh Breast Unit, Western General Hospital, Edinburgh, UK. · Carol Franc Buck Breast Care Center, University of California, San Francisco, CA, USA. · Department of Radiotherapy and Radiation Oncology, Landeskrankenhaus, Paracelsus Medical University, Salzburg, Austria. · Department of Gynecology and Obstetrics, Interdisciplinary Breast Center, Klinikum Esslingen, Esslingen, Germany. · Institute of Pathology, Medical University of Graz, Graz, Austria. · Department of Gynecology, General Hospital Leoben, Leoben, Austria. · German Breast Group, Neu-Isenburg, and Department of Gynecology and Obstetrics, University Women's Hospital, Frankfurt, Germany. · Department of Radiation Oncology, Ohio State University, Columbus, OH, USA. · Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26205180
  • Catherine Van Poznak and Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI · Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA · Robert C. Bast, Ana M. Gonzalez-Angulo, and William F. Symmans, University of Texas MD Anderson Cancer Center, Houston · Robert G. Mennel, Texas Oncology, Dallas, TX · Massimo Cristofanilli, Thomas Jefferson University-Kimmel Cancer Center, Philadelphia, PA · Matthew P. Goetz and Minetta C. Liu, Mayo Clinic, Rochester, MN · David G. Hicks, University of Rochester Medical Center, Rochester, NY · Elizabeth G. Hill, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC · Wanda Lucas, Georgetown University, Washington, DC · Ingrid A. Mayer, Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TN · and Lyndsay N. Harris, Seidman Cancer Center, Case Western Reserve University, Cleveland, OH. · Pubmed 26195705
  • Department of Pathology, Yale University, New Haven, USA · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston. · Division of Subspecialty General Surgery, Mayo Clinic, Rochester, USA. · Oncology Centre, Cambridge University Hospitals National Health Services Foundation Trust, Cambridge, UK. · Division of Early Drug Development for Innovative Therapies, European Institute of Oncology, Milan, Italy. · Edinburgh Breast Unit, Western General Hospital, Edinburgh, UK. · Carol Franc Buck Breast Care Center, University of California, San Francisco, USA. · Department of Radiotherapy and Radiation Oncology, Landeskrankenhaus, Paracelsus Medical University, Salzburg, Austria. · Department of Gynecology and Obstetrics, Interdisciplinary Breast Center, Klinikum Esslingen, Essligen, Germany. · Institute of Pathology, Medical University of Graz, Graz Breast Center Salzburg, Paracelsus Medical University, University Hospital Salzburg, Salzburg, Austria. · German Breast Group, Neu-Isenburg, and University Women's Hospital, Frankfurt, Germany. · Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center, Columbus. · Department of Diagnostic Radiology, The University of Texas M.D. Anderson Cancer Center, Houston. · Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, USA. · Institute of Pathology, Charité Hospital, Campus Mitte, Berlin, Germany. · Department of Biopathology, Institut Bergonié, Bordeaux. · Centre Jean Perrin, Clermont-Ferrand, and Université d'Auvergne, France. · Department of Pathology, European Institute of Oncology and University of Milan, Milan, Italy. · Edinburgh Cancer Research UK Centre, The University of Edinburgh, Edinburgh, UK. · Pubmed 26019189
  • Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut. · Department of Surgery, Curie Institute, Paris, France. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26275950
  • Departments of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut, United States of America. · Pubmed 26136146
  • 1] Institute of Pathology, Medical University of Graz, Graz, Austria [2] Department of Gynecology, General Hospital Leoben, Leoben, Austria. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA. · Department of Pathology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, UT, USA. · MLD Pathology, Houston, TX, USA. · Pubmed 25932963
2014
  • Department of Breast Medical Oncology Department of Systems Biology · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston. · Department of Breast Medical Oncology. · Genenetech, San Francisco. · Departments of Biostatistics. · Clinical Cancer Prevention. · Radiology. · Pathology, The University of Texas MD Anderson Cancer Center, Houston. · Division of Hematology-Oncology, Yale University, New Haven. · Department of Systems Biology. · Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, USA. · Pubmed 24669015
  • Section of Medical Oncology, Yale Cancer Center, Yale School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA. · Department of Pathology, UT M.D. Anderson Cancer Center, P.O. Box 85, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Department of Bioinformatics and Computational Biology, UT M.D. Anderson Cancer Center, P.O. Box 301402, Houston, TX 77230, USA. · Section of Medical Oncology, Yale Cancer Center, Yale School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA. Electronic address: · Pubmed 24602449
2013
  • Affiliations of authors: Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD (MCP, LMM) · Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada (SCYL, DG, EM, TON) · Department of Laboratory Medicine and Pathology, University of Alberta, Alberta, Canada (JCH) · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy (MGM) · Division of Pathology and Laboratory Medicine, European Institute of Oncology, and University of Milan, Milan, Italy (GV) · Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom (LAZ) · Department of Pathology, Centre Jean Perrin, Clermont-Ferrand, and Université d'Auvergne, France (FP-L) · Transformative Pathology, Ontario Institute for Cancer Research, Toronto, Ontario, Canada (JMSB) · PhenoPath Laboratories, Seattle, WA (AMG) · Department of Pathology, MD Anderson Cancer Center, Houston, TX (WFS) · Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, United Kingdom (TP) · The EMMES Corporation, Rockville, MD (RAE) · Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI (DFH) · Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom (MD) · on behalf of the International Ki67 in Breast Cancer Working Group of the Breast International Group and North American Breast Cancer Group. · Pubmed 24203987
2017
  • *Mayo Clinic, Rochester, MN †Alliance Statistics and Data Center, Weill Medical College of Cornell University, New York, NY ‡Alliance Statistics and Data Center, Duke University, Durham, NC §The University of Texas MD Anderson Cancer Center, Houston, TX ¶NRG Oncology and The Allegheny Health Network, Pittsburgh, PA ||SWOG and University of Washington Medical Center, Seattle, WA. · Pubmed 28657941
  • Houston, Texas From the Departments of Plastic and Reconstructive Surgery, Biostatistics, Pathology, Breast Medical Oncology, Surgical Oncology, and Radiation Oncology, The University of Texas M. D. Anderson Cancer Center. · Pubmed 28234813
2014
  • Yale University School of Medicine, New Haven, Connecticut, USA; Foundation Medicine, Cambridge, Massachusetts, USA; MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 24710307
2013
  • Authors' Affiliations: Morgan Welch Inflammatory Breast Cancer Research Program and Clinic; Departments of Breast Medical Oncology, Bioinformatics and Computational Biology, Pathology, and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; and Department of Biochemistry, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee. · Pubmed 23948975
Unspecified
2017
  • Department of Diagnostic Radiology, Unit 1350 · Department of Biostatistics, Unit 1411. · Department of Pathology, Unit 1445. · Department of Breast Medical Oncology, Unit 1354. · Department of Breast Surgical Oncology, Unit 1434, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Diagnostic Radiology, Unit 1350. · Pubmed 28314842
2014
  • Authors' Affiliations: Departments of Investigational Cancer Therapeutics, Surgical Oncology, · Authors' Affiliations: Departments of Investigational Cancer Therapeutics. · Biostatistics. · Pathology. · Radiology, Current Institution Department of Radiology, Ohio State University, Columbus, Ohio. · Radiology. · Surgical Oncology. · Breast Medical Oncology, Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas; and. · Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas; and. · Pubmed 24895461
2014
Baylor College of Medicine
2017
  • Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Pathology Administration, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA. · Department of Cellular and Molecular Medicine, University of Arizona Cancer Center, Tucson, Arizona, USA. · School of Medicine, University of Nottingham, Nottingham, UK. · Quintiles Transnational Corp, Denver, Colorado, USA. · Pubmed 27881578
University of Texas Austin
2016
  • From University of California, San Francisco (UCSF) (H.S.R., C.Y., L.J.V., M.B.B., N.M.H., A.J.C., C.E., J.L., S.E.D., G.L.H., L.J.E.), and QuantumLeap Healthcare Collaborative (M.P.), San Francisco, Buck Institute for Research and Aging, Novato (C.Y.), University of California, Davis, Davis (M.H.), University of California San Diego, San Diego (A.M.W., R.S.), and University of Southern California, Los Angeles (D.T.) - all in California · University of Chicago (O.I.O., R.N.), and Loyola University (K.S.A.), Chicago · University of Pennsylvania, Philadelphia (A.D.) · Gemini Group, Ann Arbor, MI (J.P.) · University of Texas M.D. Anderson Cancer Center, Houston (W.F.S., L.P., S.L.M., D.A.B.), UT Southwestern Medical Center, Dallas (D.M.E., B.B.H.), and Berry Consultants, Austin (A.S., D.A.B.) - all in Texas · University of Minnesota, Minneapolis (D.Y.), and Mayo Clinic, Rochester (J.C.B., T.C.H.) - both in Minnesota · Swedish Medical Center, Seattle (H.G.K.) · Georgetown Lombardi Comprehensive Cancer Center, Washington, DC (M.C.L., C.I.) · University of Kansas, Lawrence (Q.J.K.) · University of Arizona, Tucson (J.E.L., R.K.V.), and Mayo Clinic, Scottsdale (D.W.N.) - both in Arizona · Oregon Health and Sciences University, Portland (S.Y.C., K.A.K.) · University of Denver, Denver (A.D.E.) · Inova Fairfax Hospital, Falls Church, VA (K.K.E.) · and Emory University, Atlanta (W.C.W.). · Pubmed 27406347
  • From University of California, San Francisco (J.W.P., C.Y., L.J.V., N.M.H., M.B.B., A.J.C., M.M., J.L., S.E.D., G.L.H., L.J.E.), and QuantumLeap Healthcare Collaborative (M.P.), San Francisco, Buck Institute for Research and Aging, Novato (C.Y.), University of California, Davis, Davis (M.H.), University of California, San Diego, San Diego (A.M.W., R.S., T.H.), and University of Southern California, Los Angeles (D.T.) - all in California · Georgetown Lombardi Comprehensive Cancer Center, Washington, DC (M.C.L., C.I.) · University of Minnesota, Minneapolis (D.Y., T.C.H.), and Mayo Clinic, Rochester (J.C.B.) - both in Minnesota · M.D. Anderson Cancer Center, Houston (W.F.S., L.P., S.L.M., D.A.B.), University of Texas Southwestern Medical Center, Dallas (D.M.E., B.B.H.), and Berry Consultants, Austin (A.S., D.A.B.) - all in Texas · Gemini Group, Ann Arbor, MI (J.P.) · University of Pennsylvania, Philadelphia (A.D.) · Oregon Health and Sciences University, Portland (S.Y.C., K.A.K.) · Swedish Medical Center, Seattle (H.G.K.) · University of Chicago (R.N.) and Loyola University (K.S.A.) - both in Chicago · Inova Fairfax Hospital, Falls Church, VA (K.K.E.) · University of Denver, Denver (A.D.E.) · Mayo Clinic, Scottsdale (D.W.N.), and University of Arizona, Tucson (J.E.L., R.K.V.) - both in Arizona · University of Kansas, Lawrence (Q.J.K.) · and Emory University, Atlanta (W.C.W.). · Pubmed 27406346
University of Texas Southwestern
2016
  • From University of California, San Francisco (UCSF) (H.S.R., C.Y., L.J.V., M.B.B., N.M.H., A.J.C., C.E., J.L., S.E.D., G.L.H., L.J.E.), and QuantumLeap Healthcare Collaborative (M.P.), San Francisco, Buck Institute for Research and Aging, Novato (C.Y.), University of California, Davis, Davis (M.H.), University of California San Diego, San Diego (A.M.W., R.S.), and University of Southern California, Los Angeles (D.T.) - all in California · University of Chicago (O.I.O., R.N.), and Loyola University (K.S.A.), Chicago · University of Pennsylvania, Philadelphia (A.D.) · Gemini Group, Ann Arbor, MI (J.P.) · University of Texas M.D. Anderson Cancer Center, Houston (W.F.S., L.P., S.L.M., D.A.B.), UT Southwestern Medical Center, Dallas (D.M.E., B.B.H.), and Berry Consultants, Austin (A.S., D.A.B.) - all in Texas · University of Minnesota, Minneapolis (D.Y.), and Mayo Clinic, Rochester (J.C.B., T.C.H.) - both in Minnesota · Swedish Medical Center, Seattle (H.G.K.) · Georgetown Lombardi Comprehensive Cancer Center, Washington, DC (M.C.L., C.I.) · University of Kansas, Lawrence (Q.J.K.) · University of Arizona, Tucson (J.E.L., R.K.V.), and Mayo Clinic, Scottsdale (D.W.N.) - both in Arizona · Oregon Health and Sciences University, Portland (S.Y.C., K.A.K.) · University of Denver, Denver (A.D.E.) · Inova Fairfax Hospital, Falls Church, VA (K.K.E.) · and Emory University, Atlanta (W.C.W.). · Pubmed 27406347
  • From University of California, San Francisco (J.W.P., C.Y., L.J.V., N.M.H., M.B.B., A.J.C., M.M., J.L., S.E.D., G.L.H., L.J.E.), and QuantumLeap Healthcare Collaborative (M.P.), San Francisco, Buck Institute for Research and Aging, Novato (C.Y.), University of California, Davis, Davis (M.H.), University of California, San Diego, San Diego (A.M.W., R.S., T.H.), and University of Southern California, Los Angeles (D.T.) - all in California · Georgetown Lombardi Comprehensive Cancer Center, Washington, DC (M.C.L., C.I.) · University of Minnesota, Minneapolis (D.Y., T.C.H.), and Mayo Clinic, Rochester (J.C.B.) - both in Minnesota · M.D. Anderson Cancer Center, Houston (W.F.S., L.P., S.L.M., D.A.B.), University of Texas Southwestern Medical Center, Dallas (D.M.E., B.B.H.), and Berry Consultants, Austin (A.S., D.A.B.) - all in Texas · Gemini Group, Ann Arbor, MI (J.P.) · University of Pennsylvania, Philadelphia (A.D.) · Oregon Health and Sciences University, Portland (S.Y.C., K.A.K.) · Swedish Medical Center, Seattle (H.G.K.) · University of Chicago (R.N.) and Loyola University (K.S.A.) - both in Chicago · Inova Fairfax Hospital, Falls Church, VA (K.K.E.) · University of Denver, Denver (A.D.E.) · Mayo Clinic, Scottsdale (D.W.N.), and University of Arizona, Tucson (J.E.L., R.K.V.) - both in Arizona · University of Kansas, Lawrence (Q.J.K.) · and Emory University, Atlanta (W.C.W.). · Pubmed 27406346
Miscellaneous institutions in Boston
2015
  • Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet, Brussels Department of Pathology and TCRU, GZA, Antwerp, Belgium. · Institute of Pathology, Charité -University Hospital, Berlin, Germany. · Perlmutter Cancer Center, New York University Medical School, New York, USA. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · European Institute of Oncology (IEO) and University of Milan, Milan, Italy. · Department of Pathology GZA, TCRU Hospitals and CORE Antwerp University, Antwerp, Belgium. · Genomic Health, Inc., Redwood City, USA University of California San Francisco, San Francisco, USA. · Clermont-Ferrand Biopathology, University of Auvergne, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France. · Division of Haematology/Medical Oncology and. · Department of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Jacksonville. · Department of Pathology, The UT M.D. Anderson Cancer Center, Boston. · Department of Pathology, Brigham and Women's Hospital, Boston Department of Cancer Biology, Dana Farber Cancer Institute, Boston. · Department of Cancer Biology, Dana Farber Cancer Institute, Boston Department of Cancer Biology, Harvard Medical School, Boston, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Genomic Health, Inc., Redwood City, USA. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels. · Department of Pathology, University Hospital Leuven, Leuven, Belgium. · Department of Medicine, Department of Obstetrics and Gynecology and Women's Health, Albert Einstein Medical Center, Bronx, USA. · Laboratory Medicine Program, University Health Network, University of Toronto, Toronto. · Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, Canada. · Department of Pathology, Yale University School of Medicine, New Haven. · Department of Pathology, Stanford University Medical Centre, Stanford. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, USA. · German Breast Group, Neu-Isenburg, Germany. · Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan, Italy. · Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, USA. · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Victoria, Australia · Pubmed 25214542
Miscellaneous cities in USA
2015
  • Breast Unit, Royal Marsden Hospital, London Academic Department of Biochemistry, Royal Marsden Hospital, London Breakthrough Breast Cancer Research Centre, London · Breast Unit, Royal Marsden Hospital, London. · Clinical Trials and Statistics Unit, Institute of Cancer Research, London. · Department of Pathology, Royal Marsden Hospital, London, UK. · Division of Medical Oncology, Seattle Cancer Care Alliance, Seattle, USA. · Academic Department of Biochemistry, Royal Marsden Hospital, London. · Department of Research Oncology, Kings College, London, UK. · Department of Pathology, M.D. Anderson Cancer Centre, USA. · Breast Unit, Royal Marsden Hospital, London Academic Department of Biochemistry, Royal Marsden Hospital, London Breakthrough Breast Cancer Research Centre, London. · Pubmed 25361988
Bristol-Myers Squibb
2014
  • Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut. · New York University Langone Medical Center, New York University, New York, New York. · Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Quantitative Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Bristol-Myers Squibb Inc., New York, New York. · Pubmed 25172932
16 Other Locations Show
Yearly article counts 165999112000
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.